New gene-transport system gets more drugs to sick muscles
Reduces the risk of liver damage and other serious side effects
Read the full Story
Frontier research and innovative teaching at the interface of biology and medicine
Image of insulin-producing beta cells, courtesy of the Melton laboratory.
Coronavirus (COVID-19)
In March 2020 at the start of the Covid-19 Pandemic, Harvard University took immediate preventative measures to protect its students and employees. By May 2020, the University announced its research laboratory re-entry plan including prevention of workplace exposure and limiting contact within our research laboratories. The department in collaboration with the FAS continues to maintain many of these measures. Information and resources about Covid-19 workplace safety can be found at the link below.
HSCRB Research
Combating disease and tissue degeneration and improving human health.
This is the ultimate goal of HSCRB’s research, whether it is focused on the most basic level of cellular development or screening chemical compounds for potential drugs. Our mission is to push the frontiers of stem cell and regenerative biology, illuminating the workings of human health and disease in both basic discovery and clinical settings.
Related Links
HSCRB Education
The best place to learn about stem cell science, at the graduate and undergraduate level.
HSCRB is the place to learn about stem cell science at both the graduate level and the undergraduate level. We are committed to transforming medicine by cultivating a deeper knowledge of stem cell and regenerative biology, and to training the next generation to explore new frontiers in biomedical science. All of our students conduct independent research.
Related Links
HSCRB
by the numbers
300+
Papers published in Cell, Nature, Science, and their high-impact sister journals
100%
Undergraduates who conduct independent research
9+
Collaborating local institutes and hospitals
19
Startup companies founded by our faculty
News
A new therapy for treating Type 1 diabetes
A stem-cell-derived replacement therapy shows unprecedented early results in treating Type 1 diabetes
New gene-transport system gets more drugs to sick muscles
Reduces the risk of liver damage and other serious side effects
A detailed atlas of the developing brain
Harvard and Broad researchers combine single-cell genomic technologies to map the mouse cortex